Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000430573 | SCV000521150 | likely pathogenic | not provided | 2020-05-28 | criteria provided, single submitter | clinical testing | Published functional studies demonstrate a damaging effect with severely impaired mutant enzyme activity (Lenglet et al., 2018); Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 9199558, 9238757, 17298216, 17298218, 27769855, 29360981) |
Invitae | RCV000430573 | SCV004294973 | pathogenic | not provided | 2023-12-11 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 267 of the HMBS protein (p.Val267Met). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with acute intermittent porphyria (PMID: 9199558, 9238757; Invitae). ClinVar contains an entry for this variant (Variation ID: 381651). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt HMBS protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects HMBS function (PMID: 29360981). For these reasons, this variant has been classified as Pathogenic. |